Health Systems and Policy Monitor (HSPM)

An innovative platform that provides a detailed description of health systems and provides up-to-date information on reforms and changes that are particularly policy relevant.
For detailed information on country policy responses to the COVID-19 pandemic during 2020-2021, see our separate COVID-19 Health Systems Response Monitor (HSRM).

obs-logo

Updates

Innovative treatment for patients with Hepatitis C

21 May 2017 | Country Update

Since 2016, the very expensive interferon free treatment for Hepatitis C has been reimbursed by social health insurance for patients with stage 4 of fibrosis. Hence, innovative treatment has been made available for only 5,860 patients, while the total number of patients registered with Hepatitis C in Romania is 16,000. From 2017, the interferon free treatment for Hepatitis C will be extended to patients with less advanced stages of fibrosis (F3 and F2). The National Health Insurance House has announced that new cost-volume-outcome contracts will be signed to cover the treatment of almost 10,000 patients with Hepatitis C in different stages of fibrosis.

More information (in Romanian):
http://www.cnas.ro

Authors
  • Cristian Vlãdescu
Country

Subscribe to our newsletter

Sign Up